Need to Remove Existing Barriers for Effective Weight Loss? Study Provides Insights

Published On 2024-10-24 02:30 GMT   |   Update On 2024-10-24 02:30 GMT
Advertisement
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a new study led by researchers at Yale School of Public Health and the University of Florida. The findings highlight the critical need to remove existing barriers that are hindering people’s access to effective weight loss treatments and impeding public health efforts to address the national obesity crisis, the researchers said
Advertisement
Medications like glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and dual gastric inhibitory polypeptide and GLP-1 (GIP/GLP-1) receptor agonists, such as tirzepatide, have shown promise in clinical trials and are increasingly being used for weight management.
In conducting their study, the researchers aimed to quantify the potential mortality impact of increased access to these weight-loss drugs. They integrated data on mortality risk associated with different body mass index (BMI) categories, obesity prevalence, and the current limitations on drug access due to high costs and insurance restrictions.
The study highlights a critical disparity in drug access. Currently, the high cost of these medications, limits their availability.
Reference: Pandey A, Ye Y, Wells CR, Singer BH, Galvani AP. Estimating the lives that could be saved by expanded access to weight-loss drugs. Proceedings of the National Academy of Sciences. 2024 Oct 22;121(43):e2412872121.
Full View
Tags:    
Article Source : Proceedings of the National Academy of Sciences

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News